Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0043 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-006 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-145 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-14 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
filingDate |
2006-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2008-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2008530070-A |
titleOfInvention |
Novel pharmaceutical composition useful for transmucosal administration of drugs |
abstract |
A pharmaceutical composition in the form of a homogeneous interaction mixture is provided, the composition comprising a pharmacologically effective amount of the active ingredient in the form of microparticles having a particle size of about 0.5 μm to about 10 μm, the particles comprising about 10 Adhered to the surface of larger carrier particles in the particle size range of ˜about 100 μm. This carrier particulate material is preferably biologically and / or mucoadhesive in nature. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018124062-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7272738-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2018124062-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7076171-B2 |
priorityDate |
2005-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |